| http://www.w3.org/ns/prov#value | - In combination with gemcitabine, Tarceva is also indicated for the first-line treatment of patients with locally advanced, unresectable, or metastatic pancreatic cancer.Read the complete MedWatch 2009 Safety summary, including a link to the OSI Dear Healthcare Professional Letter, at:http://www.fda.gov/medwatch/safety/2009/safety09.htm#Tarceva Publicado por
|
